Chance reductions appear to be greater with minimal rather then medium or superior doses, vaginal or transdermal as an alternative to oral preparations, and with estradiol rather then conjugated estrogen.I think the rest is connected with where by the reimbursement is. Telehealth is right there. The point that the Centers for Medicare and Medicaid